Suppression of lung cancer in murine model: treated by combination of recombinant human endostsatin adenovirus with low-dose cisplatin

BACKGROUND: The sustained growth of tumors necessitates neovascularization. As one of the potent endogenous vascular inhibitors, endostatin has been widely used in antiangiogenesis therapy for tumor. Cisplatin is normally administered in chemotherapy for lung cancer but accompanied with serious side...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Rui Z, Wu, Yang, Liu, Quan, Xie, Ke, Wei, Yu Q, Wang, Yong S, Liu, Kang, Luo, Yan, Su, Jing M, Hu, Bing, Liu, Ji Y, Li, Qiu, Niu, Ting, Zhao, Zhi W, Yang, Li
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657125/
https://www.ncbi.nlm.nih.gov/pubmed/19265510
http://dx.doi.org/10.1186/1756-9966-28-31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657125/
https://www.ncbi.nlm.nih.gov/pubmed/19265510
http://dx.doi.org/10.1186/1756-9966-28-31

Ejemplares similares